title: WAGR syndrome in a baby--the result of 6-MP treatment in a father affected by Crohn's disease?
authors.forename: Z
authors.initials: Z
authors.lastname: Ben-Neriah
authors.forename: Z
authors.initials: Z
authors.lastname: Ackerman
mesh_terms: D000328:Adult; D003424:Crohn Disease / Q000175:diagnosis / Q000188:drug therapy*; D005220:Fathers; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007231:Infant, Newborn; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use; D018812:Paternal Exposure / Q000009:adverse effects*; D018570:Risk Assessment; D017624:WAGR Syndrome / Q000175:diagnosis / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents; D015122:Mercaptopurine